Potentials our cell therapy technologies using Japanese biomaterials for future collaboration between Japan and overseas partners for commercialization and further research.
For details please see the cover story of Eurobiz July.

Potentials our cell therapy technologies using Japanese biomaterials for future collaboration between Japan and overseas partners for commercialization and further research.
For details please see the cover story of Eurobiz July.
A curiosity driven sojourn, across disciplines in science, led to the discovery of a safe adjuvant hidden in a beta glucan giving hope to patients with muscular dystrophy; A story of ZeitenWende all along, blessed with good people, hopefully a modest contribution to humanity by connecting the dots.
Published in Scientific Reports, a nature portfolio journal 15 November 2023 Significant reduction of muscle f
Edogawa NICHE Prize 2020 lecture by Dr. John Craig Venter, geneticist and a pioneer in human genome research in Toronto
Dr John Craig Venter to deliver the lecture in UHN Ajmera Transplant Center in University of Toronto
Cliny PEG Gastrostomy kits of Create Medic launched in India by Medinippon, GNCorp sister company 11Aug2023 Ja
Japanese scientists, research collaborators to Nichi-in Centre for Regenerative Medicine (NCRM) have reported an increased yield of Beta 1,3-1,6 glucans in the produc
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome
Manuscript published in Stem Cell Reviews and Reports